Before DC‘s and Marvel‘s superheroes dominated the comic book world, horror stories were among the most popular genres in the ...

Eli Lilly & Co. agreed to buy Verve Therapeutics Inc., a US biotech that’s seeking to use gene editing to prevent clogged arteries, for as much as $1.3 billion.

Eli Lilly to Acquire Gene-Editing Therapy Developer Verve Therapeutics for up to $1.3 Billion, Companies Say. By Reuters | June 17, 2025. By Reuters | June 17, 2025, at 6:54 a.m. Save Comment.

WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. Sarepta reported ...

For someone with magic and technology on his side, Doctor Doom is physically stronger than given credit for, and these ...

The late, great Gene Hackman was one of the finest actors to ever grace a cinema screen. When he died in February 2025, the outpouring of love and affection for him and his work was overwhelming. He ...

2025 Belmont Stakes picks, odds: Horse racing writer has best bets for final jewel of Triple Crown SportsLine horse racing writer Gene Menez, who crushed the late Pick 4 on Breeders' Cup Saturday for ...

With an estimated four million Nigerians affected by sickle cell disease, experts have called on the federal government to invest in the local production of gene therapy treatments. The appeal was ...

Using a tool called Automated Meiotic Mapping (AMM) that was developed at UT Southwestern Medical Center, a team of researchers has identified a gene that appears to be key to regulating food intake.

Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and speed of new drug approvals.

CALDWELL, Texas (KBTX) -Law enforcement officers, community leaders, and family gathered Thursday afternoon to honor the life and legacy of Burleson County Sheriff Gene Hermes. Visitation was held ...

“We estimate that over 100 rare disease gene therapy products that had reached clinical stage have been discontinued since 2023 — not because of treatment failure, but because of the risk of market ...